Company news

Cynata Therapeutics Limited news in 2021

Cynata Therapeutics Limited's news releases, calls and decks from 2021, newest first.

View company

FUJIFILM Cellular Dynamics Executes Manufacturing Agreement

December 28, 2021

Cynata Commences DFU Clinical Trial

December 21, 2021

Site Initiation Visit Completed for CYP DFU Clinical Trial

November 17, 2021

Cynata Receives US$5m Fujifilm Fee

October 17, 2021

DSMB Recommends Continuation of Cynatas MEND Trial

October 7, 2021

Cynata Enters into a New Strategic Partnership with Fujifilm

September 30, 2021

Further Patents for Cynata Unique Cymerus Technology

September 15, 2021

Further Canadian Patent for Cynata

August 30, 2021

Cynata Receives Notice of Allowance from US Patent Office

August 26, 2021

Ethics Approval for Cynatas Clinical Trial in DFU

June 30, 2021

Progress Toward Clinical Trial in Diabetic Foot Ulcers

June 27, 2021

Cynata signs Licence Agreement with TekCyte

June 3, 2021

First Patient Enrolled in Cynata MEND Clinical Trial

May 24, 2021

Cynata Therapeutics Expands MEND clinical trial in COVID-19 and Respiratory Failure

March 29, 2021

Cynata Expands trial in COVID-19 & Respiratory Failure

March 28, 2021

New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs

March 2, 2021

Cynata Therapeutics Advances Planned Clinical Trial in Diabetic Foot Ulcers in MoU With TekCyte

March 1, 2021

Cynata Receives $1.39m R&D Tax Incentive Refund

February 21, 2021

Completion of Entitlement Offer and Shortfall Placement

January 17, 2021

Decks in 2021